On-Demand Webinars
-
CMC And Clinical Strategies For Developing Injectable, Oral Peptide Drugs
2/6/2025
In this session, Chief Scientific Officer Dr. Andy Lewis delves into the key drivers shaping peptide drug development and explores innovative delivery options to enhance therapeutic outcomes.
-
LBA Vs. LC-MS: Competing Technologies At A Development Crossroad
2/6/2025
Watch as bioanalytical experts Shane Karnik, MS, and Matt Hartle, Ph.D., explore why many sponsors are reevaluating the use of LBA for large molecule protein analysis in favor of LC-MS.
-
The Next Frontier In mRNA: Modular Manufacturing For Scalable RNA-LNP Therapies
1/29/2025
Explore constructing a modular RNA-LNP GMP facility using Cytiva's FlexFactory™ process train in a KUBio™ environment to scale RNA-LNP therapies.
-
Developing And Manufacturing Minitablets To Extend Drug Lifecycle
1/27/2025
Pharmaceutical companies should leverage oral minitablets to extend drug lifecycles, optimize dosing, and improve patient-centric solutions while overcoming manufacturing challenges.
-
Adapting To Demand: The Importance Of Flexibility In HPAPI Small-Batch Manufacturing
1/27/2025
Watch as experts provide insight into the challenges of HPAPI manufacturing and offer proven strategies for achieving the flexibility required for small-batch production.
-
Innovations In Orally Disintegrating Tablets For Pediatric Drug Delivery
1/27/2025
Delve into the evolving landscape of pediatric dosage forms, with a focus on how ODTs are emerging as a specialized and practical drug delivery system for children.
-
Accelerating Clinical Development: Modern Tools In Process Chemistry
1/23/2025
Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.
-
Achieving Desired Particle Size And Yield Through Efficient Micronization
1/22/2025
In this webinar, experts examine how the right combination of advanced technology and specialized expertise can leverage micronization to address the challenges often faced by small molecule drugs.
-
Beyond CRISPR: Exploring Next-Generation Gene Editing With TARGATT, Mad7, And Base Editing
1/17/2025
Consider several groundbreaking gene editing technologies—TARGATT®, Mad7, and Base Editing—and gain insights into their transformative applications in genetic engineering and therapeutic development.
-
The Future Of Allogeneic Cell Therapy: Hypoimmunogenic Donor Cells
1/17/2025
Explore how TARGATTĀ® gene editing and HLA-F technologies are revolutionizing hypoimmunogenic cell development for scalable allogeneic therapies.